JCS/JHFS 2021 guideline focused update on diagnosis and treatment of acute and chronic heart failure

H Tsutsui, T Ide, H Ito, Y Kihara, K Kinugawa… - Circulation …, 2021 - jstage.jst.go.jp
After the publication of the revised edition, therapeutic drugs described in “Future Treatment”
were approved and important evidence for pharmacologic therapy and nonpharmacologic …

Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert Panel

JE Wilcox, JC Fang, KB Margulies, DL Mann - Journal of the American …, 2020 - jacc.org
Reverse left ventricular (LV) remodeling and recovery of LV function are associated with
improved clinical outcomes in patients with heart failure with reduced ejection fraction. A …

JCS 2017/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure―digest version―

H Tsutsui, M Isobe, H Ito, K Okumura, M Ono… - Circulation …, 2019 - jstage.jst.go.jp
Heart Failure Society (JHFS). The working committee for this project includes members and
collaborators involved in the previous versions of the heart failure guidelines and members …

[HTML][HTML] Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial

BP Halliday, R Wassall, AS Lota, Z Khalique… - The Lancet, 2019 - thelancet.com
Background Patients with dilated cardiomyopathy whose symptoms and cardiac function
have recovered often ask whether their medications can be stopped. The safety of …

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on …

CW Yancy, M Jessup, B Bozkurt, J Butler… - Journal of the American …, 2013 - jacc.org
2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American
College of Cardiology Foundation/American Heart Association Task Force on Practice …

[HTML][HTML] Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial

O Vardeny, JC Fang, AS Desai, PS Jhund, B Claggett… - Nature medicine, 2022 - nature.com
With modern treatments for heart failure with reduced ejection fraction (EF), indicative of
impaired cardiac systolic function, patients may exhibit an increase in EF. Limited data are …

Rehospitalization for heart failure: predict or prevent?

AS Desai, LW Stevenson - Circulation, 2012 - Am Heart Assoc
Heart failure is the leading cause of hospitalization among adults 65 years of age in the
United States. Annually, 1 million patients are hospitalized with a primary diagnosis of heart …

Characteristics and outcomes of adult outpatients with heart failure and improved or recovered ejection fraction

AP Kalogeropoulos, GC Fonarow… - JAMA …, 2016 - jamanetwork.com
Importance Heart failure (HF) guidelines recognize that a subset of patients with HF and
preserved left ventricular ejection fraction (LVEF) previously had reduced LVEF but …

Prevalence and prognostic implications of longitudinal ejection fraction change in heart failure

G Savarese, O Vedin, D D'Amario, A Uijl, U Dahlström… - JACC: Heart Failure, 2019 - jacc.org
Objectives: This study sought to evaluate the incidence, the predictors, and the associations
with outcomes of changes in ejection fraction (EF) in heart failure (HF) patients. Background …

Domain management approach to heart failure in the geriatric patient: present and future

EZ Gorodeski, P Goyal, SL Hummel… - Journal of the American …, 2018 - jacc.org
Heart failure (HF) is a quintessential geriatric cardiovascular condition, with more than 50%
of hospitalizations occurring in adults age 75 years or older. In older patients, HF is closely …